Trump on Five Days of Remdesivir and Days 7-10 Are Critical in COVID Sickness
The medical team of doctors at Walter Reed gave an update on President Trumps COVID treatment. They said he is on a 5-day course of the drug Remdesivir.
Trump is being given a 5-day course of Remdesivir. He was previously given a cocktail of antibodies.
Trump first showed symptoms and was diagnosed on October 1. The doctors said days 7-10 are usually the most important days when the risk is highest for someone to become very sick. Trump has been given a lot of new treatments at the earliest points. This should mean less chance for a severe case and a better chance for early recovery. However, the drugs are not perfect and might reduce the chance of a severe case by 80%.
Early statistics would suggest that Trump has 3% chance of death and 10-15% chance of severe illness. The odds might be less than 1% chance of death and 2-3% chance of severe illness. However, the statistics are not very precise and there are many factors.
Every person infected with Covid is a step backwards in our effort to slow pandemic and reopen society. A 74-year-old has approximately 3% chance of death, 10-15% chance of severe illness. Higher in males, obesity. Remdesivir, monoclonal ab, convalescent serum unproven, may help.
— Dr. Tom Frieden (@DrTomFrieden) October 2, 2020
If President Trump becomes severely ill or dies, then the stock markets will drop substantially.
SOURCES- C-Span, Walter Reed, Dr Tom Frieden
Written By Brian Wang, Nextbigfuture.com
Brian Wang is a Futurist Thought Leader and a popular Science blogger with 1 million readers per month. His blog Nextbigfuture.com is ranked #1 Science News Blog. It covers many disruptive technology and trends including Space, Robotics, Artificial Intelligence, Medicine, Anti-aging Biotechnology, and Nanotechnology.
Known for identifying cutting edge technologies, he is currently a Co-Founder of a startup and fundraiser for high potential early-stage companies. He is the Head of Research for Allocations for deep technology investments and an Angel Investor at Space Angels.
A frequent speaker at corporations, he has been a TEDx speaker, a Singularity University speaker and guest at numerous interviews for radio and podcasts. He is open to public speaking and advising engagements.